Jeffrey Swers

Principal Scientist at Arcellx

Jeffrey Swers has a strong background in scientific research and development. Jeffrey started their career at MedImmune, where they worked as a Scientist I from April 2005 to August 2011 and then as a Scientist II from August 2011 to June 2015. Afterwards, they moved on to the National Institutes of Health, where they worked as a Senior Scientist from July 2015 to March 2016. Currently, Jeffrey works at Arcellx, Inc. as a Scientist III since April 2016 and has recently been promoted to Principal Scientist in January 2021.

Jeffrey Swers received a BSE in Chemical Engineering from Princeton University in 1999. Jeffrey then pursued a Doctor of Philosophy (Ph.D.) in Chemical Engineering at the Massachusetts Institute of Technology from 1999 to 2005.

Location

Rockville, United States

Links

Previous companies


Org chart


Teams


Offices


Arcellx

2 followers

Arcellx is a clinical-stage biopharmaceutical company developing novel, adaptive and controllable cell therapies for the treatment of patients with cancer and autoimmune diseases.


Employees

11-50

Links